Suppr超能文献

2001-2014 年巴西诊断时乳腺癌分期的民族种族和社会趋势:仅病例分析。

Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis.

机构信息

Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Population, Policy and Practice Programme, University College London Great Ormond Street Institute of Child Health, London, UK.

出版信息

Lancet Glob Health. 2019 Jun;7(6):e784-e797. doi: 10.1016/S2214-109X(19)30151-2.

Abstract

BACKGROUND

Policies for early detection of breast cancer, including clinical breast examinations and mammographic screening, were introduced in Brazil in 2004, but their effect on disease stage at diagnosis is unclear. We aimed to assess whether these policies have led to a decrease in the prevalence of late-stage breast cancer at diagnosis.

METHODS

In this case only analysis, using an anonymised nationwide hospital based-cancer registry network, we identified women aged 18-89 years who had been diagnosed with an invasive breast cancer in Brazil during 2001-14. We extracted individual patient-level data on patient demographics, tumour variables, and health-care provider variables for the centre where the patient was diagnosed. Our objectives were to estimate the prevalence of late-stage breast cancer (TNM stage III or IV) at diagnosis overall, across age groups, and by ethnoracial and social strata (ie, self-reported ethnoracial group, as white, black, brown, Asian, or Indigenous, and educational level, marital status, and region of residence) across the study period, and compare these estimates with international data from high-income countries (Norway and the USA). We used logistic regression to estimate odds ratios (ORs) for late-stage versus early-stage (TNM stage I or II) breast cancer at diagnosis in relation to relevant exposures, either minimally adjusted (for age, year of diagnosis, and region of residence) or fully adjusted (for all patient, tumour, and health-care provider variables).

FINDINGS

We identified 247 719 women who were diagnosed with invasive breast cancer between Jan 1, 2001, and Dec 31, 2014, with a mean age at diagnosis of 55·4 years (SD 13·3), of whom 36·2% (n=89 550) identified as white, 29·8% (n=73 826) as black or brown, and 0·7% (n=1639) as Asian or Indigenous. Prevalence of late-stage breast cancer at diagnosis remained high throughout 2001-14, at approximately 40%, was inversely associated with educational level (p value for linear trend <0·0001), and was higher for women who identified as black (minimally adjusted OR 1·61, 95% CI 1·53-1·70; fully adjusted OR 1·45, 95% CI 1·38-1·54) and brown (minimally adjusted OR 1·26, 95% CI 1·22-1·30; fully adjusted OR 1·18, 1·14-1·23) than those who identified as white. The predicted prevalence of late-stage cancer at diagnosis was highest for women who were black or brown with little or no formal education (48·8%, 95% CI 48·2-49·5) and lowest for women who were white with university education (29·4%, 28·2-30·6), but both these prevalences were higher than that of all women diagnosed with breast cancer in Norway before the introduction of mammography screening (ie, 16·3%, 95% CI 15·4%-17·2% in 1970-74). Similar ethnoracial and social patterns emerged in analyses restricted to the age group targeted by screening (50-69 years).

INTERPRETATION

The persistently high prevalence of late-stage breast cancer at diagnosis across all ethnoracial and social strata in Brazil, although more substantially among the most disadvantaged populations, implies that early detection policies might have had little effect on breast cancer mortality so far, and highlights the need to focus primarily on timely diagnosis of symptomatic breast cancer rather than on screening for asymptomatic disease.

FUNDING

Newton Fund, Research Councils UK, and Conselho Nacional das Fundações Estaduais de Amparo à Pesquisa.

摘要

背景

包括临床乳房检查和乳房 X 光筛查在内的乳腺癌早期检测政策于 2004 年在巴西推出,但这些政策对诊断时疾病分期的影响尚不清楚。我们旨在评估这些政策是否导致诊断时晚期乳腺癌的患病率降低。

方法

在这项仅基于病例的分析中,我们利用一个匿名的全国性基于医院的癌症登记网络,确定了 2001 年至 2014 年期间在巴西被诊断为浸润性乳腺癌的 18-89 岁女性。我们提取了每位患者的个人患者水平数据,包括患者人口统计学、肿瘤变量和就诊中心的医疗服务提供者变量。我们的目标是评估总体、各年龄组以及按种族和社会阶层(即自我报告的种族群体,分为白种人、黑种人/棕色人种、亚洲人或原住民,以及教育程度、婚姻状况和居住地区)诊断时晚期乳腺癌(TNM 分期 III 或 IV 期)的患病率,并将这些估计值与高收入国家(挪威和美国)的国际数据进行比较。我们使用逻辑回归来估计相关暴露因素与早期(TNM 分期 I 或 II 期)乳腺癌相比的晚期乳腺癌(TNM 分期 III 或 IV 期)的比值比(OR),这些暴露因素要么是最小调整(按年龄、诊断年份和居住地区调整),要么是完全调整(按所有患者、肿瘤和医疗服务提供者变量调整)。

结果

我们确定了 2001 年 1 月 1 日至 2014 年 12 月 31 日期间被诊断为浸润性乳腺癌的 247719 名女性,平均诊断年龄为 55.4 岁(标准差 13.3),其中 36.2%(n=89550)自我报告为白种人,29.8%(n=73826)为黑种人/棕色人种,0.7%(n=1639)为亚洲人或原住民。诊断时晚期乳腺癌的患病率在整个 2001-14 年期间一直居高不下,约为 40%,与教育程度呈负相关(线性趋势 p 值<0.0001),且黑种人(最小调整 OR 1.61,95%CI 1.53-1.70;完全调整 OR 1.45,95%CI 1.38-1.54)和棕色人种(最小调整 OR 1.26,95%CI 1.22-1.30;完全调整 OR 1.18,1.14-1.23)的患病率高于自我报告为白种人的女性。预测诊断时晚期癌症的患病率最高的是受教育程度低或没有接受正规教育的黑种人和棕色人种女性(48.8%,95%CI 48.2-49.5),最低的是接受大学教育的白种人女性(29.4%,28.2-30.6),但这两种患病率均高于挪威在引入乳房 X 光筛查前所有乳腺癌患者的患病率(即 1970-74 年的 16.3%,95%CI 15.4%-17.2%)。在仅针对筛查目标年龄组(50-69 岁)的分析中,出现了类似的种族和社会模式。

解释

巴西所有种族和社会阶层的诊断时晚期乳腺癌的患病率仍然很高,尽管在最弱势群体中更为明显,这意味着早期检测政策迄今为止对乳腺癌死亡率的影响可能很小,并强调需要将重点主要放在及时诊断有症状的乳腺癌上,而不是筛查无症状疾病。

资金

牛顿基金会、英国研究理事会和巴西州立研究支持基金会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdf/6527520/f8ccb898033a/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验